Gynecomastia risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 13: | Line 13: | ||
* Drugs (12765) | * Drugs (12765) | ||
** Spironolactone | ** Spironolactone<ref name="pmid907238">{{cite journal| author=Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH| title=Pathophysiology of spironolactone-induced gynecomastia. | journal=Ann Intern Med | year= 1977 | volume= 87 | issue= 4 | pages= 398-403 | pmid=907238 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=907238 }} </ref> | ||
** Cimetidine | ** Cimetidine | ||
** Recombinant Human Growth Hormone | ** Recombinant Human Growth Hormone | ||
Revision as of 16:36, 18 May 2017
|
Gynecomastia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gynecomastia risk factors On the Web |
|
American Roentgen Ray Society Images of Gynecomastia risk factors |
|
Risk calculators and risk factors for Gynecomastia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Risk Factors
Risk factors
- The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.
Common Risk Factors
- Idiopathic
- Drugs (12765)
- Cirrhosis
- Starvation and Refeeding
- Male hypogonadism
- Testicular neoplasms
- Hyperthyroidism
- Chronic Kidney disease
- Tumors
Less Common Risk Factors
- Feminizing adrenal tumors
- Ectopic hCG
- Disorders of sex development
- Familial prepubertal gynecomastia
References
- ↑ Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH (1977). "Pathophysiology of spironolactone-induced gynecomastia". Ann Intern Med. 87 (4): 398–403. PMID 907238.
- ↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.